Human CD 133 Positive (CD133+) Bone Marrow Cells

Description

CD133+ Human Bone Marrow Cells are isolated from human bone marrow using magnetic cell sorting to ensure high purity. Depending on experimental requirements, these cells may be obtained from a single donor or pooled from multiple donors. After isolation, the cells are cryopreserved. CD133 is a well-established marker for stem and progenitor cells, and CD133+ cells have been widely studied for their regenerative potential. In cancer research, CD133+ cells are often recognized as cancer stem cells (CSCs), which are believed to drive tumor growth, metastasis, and therapy resistance. Human CD133+ bone marrow cells offer a robust model for studying stem cell biology, oncology, and regenerative medicine. To maintain viability and functionality, repeated freeze-thaw cycles should be avoided during cell handling and culture. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.